Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Gauthier

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Bone Marrow Transplantation|November 12, 2024
Correction: Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicityEmily C Liang, Kai Rejeski, Teng Fei, et al.
Bulletin Du Cancer|November 5, 2016
[Management of graft failure and erythroblastopenia in patients undergoing allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jérôme Cornillon, Flore Sicre de Fontbrune, Sylvain Chantepie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 21, 2017
Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host DiseaseThomas Hueso, Jordan Gauthier, Marie Joncquel Chevalier-Curt, et al.
Bone Marrow Transplantation|April 16, 2024
Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicityEmily C Liang, Kai Rejeski, Teng Fei, et al.
Blood Advances|October 19, 2021
Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapyKrishna R Juluri, Qian Vicky Wu, Jenna Voutsinas, et al.
Hemasphere|August 8, 2024
PD-L1<sup>+</sup> macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B-cell lymphoma microenvironment impact CD19 CAR-T cell immunotherapy efficacyAlexandre V Hirayama, Jocelyn H Wright, Kimberly S Smythe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2024
Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients With Pre-Cellular Therapy SARS-CoV-2 InfectionIla Nimgaonkar, Leah H Yoke, Pavitra Roychoudhury, et al.
Cancer Immunology Research|October 13, 2025
IL2/IL15 Signaling Induces NK Cell Production of FLT3LG, Augmenting Anti-PD-1 ImmunotherapyShayan C Avanessian, Renske J E van den Bijgaart, Nayvin W Chew, et al.
JCO Clinical Cancer Informatics|April 20, 2026
Erratum: Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing CollaborationYimei Li, Yang Qiao, Fei Gao, et al.
JCO Clinical Cancer Informatics|January 30, 2026
Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing CollaborationYimei Li, Yang Qiao, Fei Gao, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Bone Marrow Transplantation|November 12, 2024
Correction: Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicityEmily C Liang, Kai Rejeski, Teng Fei, et al.
Bulletin Du Cancer|November 5, 2016
[Management of graft failure and erythroblastopenia in patients undergoing allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jérôme Cornillon, Flore Sicre de Fontbrune, Sylvain Chantepie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 21, 2017
Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host DiseaseThomas Hueso, Jordan Gauthier, Marie Joncquel Chevalier-Curt, et al.
Bone Marrow Transplantation|April 16, 2024
Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicityEmily C Liang, Kai Rejeski, Teng Fei, et al.
Blood Advances|October 19, 2021
Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapyKrishna R Juluri, Qian Vicky Wu, Jenna Voutsinas, et al.
Hemasphere|August 8, 2024
PD-L1<sup>+</sup> macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B-cell lymphoma microenvironment impact CD19 CAR-T cell immunotherapy efficacyAlexandre V Hirayama, Jocelyn H Wright, Kimberly S Smythe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2024
Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients With Pre-Cellular Therapy SARS-CoV-2 InfectionIla Nimgaonkar, Leah H Yoke, Pavitra Roychoudhury, et al.
Cancer Immunology Research|October 13, 2025
IL2/IL15 Signaling Induces NK Cell Production of FLT3LG, Augmenting Anti-PD-1 ImmunotherapyShayan C Avanessian, Renske J E van den Bijgaart, Nayvin W Chew, et al.
JCO Clinical Cancer Informatics|April 20, 2026
Erratum: Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing CollaborationYimei Li, Yang Qiao, Fei Gao, et al.
JCO Clinical Cancer Informatics|January 30, 2026
Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing CollaborationYimei Li, Yang Qiao, Fei Gao, et al.
Pageof 9